Search Results - "FDA"

A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for denosumab by Yue He, Yue He, Rong Zhang, Huarui Shen, Yingqi Liu, Yingqi Liu

Connect to this object online.

Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats [Retraction] by Zulfiqar Z, Shah FA, Shafique S, Alattar A, Ali T, Alvi AM, Rashid S, Li S

Connect to this object online.

Value of Antibody Drug Conjugates for Gynecological Cancers: A Modern Appraisal Following Recent FDA Approvals by McNamara B, Chang Y, Goreshnik A, Santin AD

Connect to this object online.

Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system by Rui Xiong, Jing Lei, Sicen Pan, Hong Zhang, Yongtao Tong, Wei Wu, Yi Huang, Xiaodan Lai

Connect to this object online.

Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS) by Lin Zhang, Wei Mao, Dan Liu, Bin Hu, Xiaofang Lin, Jie Ran, Xingxing Li, Jing Hu

Connect to this object online.

A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database by Liyuan Liu

Connect to this object online.

FDA's proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States. by Alberto E Paniz-Mondolfi, Juan David Ramírez

Connect to this object online.

Post-Marketing Safety Concerns With Secukinumab: A Disproportionality Analysis of the FDA Adverse Event Reporting System by Yamin Shu, Yufeng Ding, Yanxin Liu, Pan Wu, Xucheng He, Qilin Zhang

Connect to this object online.

Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches by Omima S. Mohammed, Hany G. Attia, Bassim M. S. A. Mohamed, Marawan A. Elbaset, Hany M. Fayed

Connect to this object online.

A real-world disproportionality analysis of apalutamide: data mining of the FDA adverse event reporting system by Zhihong Fang, Zhiqiang Xu, Wei Zhu, Mingming Yu, Chunmei Ji

Connect to this object online.

FDA's proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States by Alberto E. Paniz-Mondolfi, Juan David Ramírez

Connect to this object online.

The FDA has approved a vaccine for the prevention of whooping cough in infants up to 2 months of life by article Editorial

Connect to this object online.

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales by Amelia D. Dahlén, Giovanna Dashi, Ivan Maslov, Ivan Maslov, Misty M. Attwood, Jörgen Jonsson, Vladimir Trukhan, Helgi B. Schiöth, Helgi B. Schiöth

Connect to this object online.

Discrepancies between FDA documents and ClinicalTrials.gov for Orphan Drug-related clinical trial data. by Mohua Chakraborty Choudhury, Indraneel Chakraborty, Gayatri Saberwal

Connect to this object online.

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib by Xusheng Zhang, Xiuli Ren, Tianyu Zhu, Wanjin Zheng, Wanjin Zheng, Chengwu Shen, Cuicui Lu

Connect to this object online.

Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysisResearch in context by Adriana M. Ivama-Brummell, Fernanda L. Marciniuk, Anita K. Wagner, Claudia G.S. Osorio-, Sabine Vogler, Elias Mossialos, Carla L. Tavares-, Huseyin Naci

Connect to this object online.

Smokers' reactions to FDA regulation of tobacco products: Findings from the 2009 ITC United States survey by Fix Brian V, O'Connor Richard J, Fong Geoffrey T, Borland Ron, Cummings K M, Hyland Andrew

Connect to this object online.

Dexmedetomidine: a real-world safety analysis based on FDA adverse event reporting system database by Yichun Shuai, Zhe Chen, Qiaoqian Wan, Jinzheng Wu, Xin Wang

Connect to this object online.

Discrepancies between FDA documents and ClinicalTrials.gov for Orphan Drug-related clinical trial data by Mohua Chakraborty Choudhury, Indraneel Chakraborty, Gayatri Saberwal

Connect to this object online.

Revisiting FDA's 1995 Guidance on Bioequivalence Establishment of Topical Dermatologic Corticosteroids: New Research Based Recommendations by Deniz Ozdin, Naveen Sharma, Jorge Lujan-Zilbermann, Philippe Colucci, Isadore Kanfer, Murray P. Ducharme

Connect to this object online.